Citigroup’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-39,243
| Closed | -$8K | – | 5266 |
|
|
2018
Q1 | $8K | Buy |
39,243
+21,270
| +118% | +$4.34K | ﹤0.01% | 4547 |
|
|
2017
Q4 | $23K | Sell |
17,973
-1,787
| -9% | -$2.29K | ﹤0.01% | 4205 |
|
|
2017
Q3 | $42K | Buy |
19,760
+6,900
| +54% | +$14.7K | ﹤0.01% | 3734 |
|
|
2017
Q2 | $37K | Buy |
12,860
+11,160
| +656% | +$32.1K | ﹤0.01% | 3733 |
|
|
2017
Q1 | $6K | Buy |
1,700
+1,400
| +467% | +$4.94K | ﹤0.01% | 4445 |
|
|
2016
Q4 | $1K | Sell |
300
-2,353
| -89% | -$7.84K | ﹤0.01% | 4837 |
|
|
2016
Q3 | $9K | Sell |
2,653
-1,960
| -42% | -$6.65K | ﹤0.01% | 4508 |
|
|
2016
Q2 | $19K | Sell |
4,613
-6,604
| -59% | -$27.2K | ﹤0.01% | 4232 |
|
|
2016
Q1 | $64K | Buy |
11,217
+5,701
| +103% | +$32.5K | ﹤0.01% | 4175 |
|
|
2015
Q4 | $95K | Sell |
5,516
-21,172
| -79% | -$365K | ﹤0.01% | 3623 |
|
|
2015
Q3 | $563K | Buy |
26,688
+23,590
| +761% | +$498K | ﹤0.01% | 2126 |
|
|
2015
Q2 | $154K | Buy |
3,098
+104
| +3% | +$5.17K | ﹤0.01% | 2944 |
|
|
2015
Q1 | $235K | Sell |
2,994
-2,980
| -50% | -$234K | ﹤0.01% | 2837 |
|
|
2014
Q4 | $362K | Sell |
5,974
-39,589
| -87% | -$2.4M | ﹤0.01% | 2711 |
|
|
2014
Q3 | $1.94M | Sell |
45,563
-3,312
| -7% | -$141K | ﹤0.01% | 1298 |
|
|
2014
Q2 | $3.02M | Sell |
48,875
-4,019
| -8% | -$248K | ﹤0.01% | 1093 |
|
|
2014
Q1 | $3.44M | Sell |
52,894
-1,847
| -3% | -$120K | ﹤0.01% | 999 |
|
|
2013
Q4 | $3.08M | Buy |
54,741
+818
| +2% | +$46.1K | ﹤0.01% | 1113 |
|
|
2013
Q3 | $3.31M | Sell |
53,923
-14,826
| -22% | -$910K | ﹤0.01% | 1051 |
|
|
2013
Q2 | $4.02M | Buy |
+68,749
| New | +$4.02M | ﹤0.01% | 960 |
|